Evaxion Biotech A/S (EVAX)

Evaxion Biotech Revenue

In the year 2024, Evaxion Biotech had annual revenue of $3.34M with 4,480.82% growth. Evaxion Biotech had revenue of $122.00K in the quarter ending December 31, 2024, with 67.12% growth.

• Revenue (ttm): $3.34M
• Revenue Growth: +4,480.82%
• P/S Ratio: 0.53
• Revenue / Employee: $72,696
• Employees: 46
• Market Cap: 10.42M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.34M	3.27M	4,480.82%
Dec 31, 2023	73.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.